185 related articles for article (PubMed ID: 23617744)
1. An international longitudinal registry of patients with atrial fibrillation at risk of stroke (GARFIELD): the UK protocol.
Apenteng PN; Murray ET; Holder R; Hobbs FD; Fitzmaurice DA;
BMC Cardiovasc Disord; 2013 Apr; 13():31. PubMed ID: 23617744
[TBL] [Abstract][Full Text] [Related]
2. Stroke prevention in patients from Latin American countries with non-valvular atrial fibrillation: Insights from the GARFIELD-AF registry.
Jerjes-Sanchez C; Corbalan R; Barretto ACP; Luciardi HL; Allu J; Illingworth L; Pieper KS; Kayani G;
Clin Cardiol; 2019 May; 42(5):553-560. PubMed ID: 30873623
[TBL] [Abstract][Full Text] [Related]
3. Temporal trends in antithrombotic treatment of real-world UK patients with newly diagnosed atrial fibrillation: findings from the GARFIELD-AF registry.
Apenteng PN; Gao H; Hobbs FR; Fitzmaurice DA;
BMJ Open; 2018 Jan; 8(1):e018905. PubMed ID: 29331969
[TBL] [Abstract][Full Text] [Related]
4. Treatment patterns in anticoagulant therapy in patients with newly diagnosed atrial fibrillation in Belgium: results from the GARFIELD-AF registry.
Cools F; Wollaert B; Vervoort G; Verstraete S; Voet J; Hermans K; Heyse A; De Wolf A; Hollanders G; Boussy T; Anné W; Vercammen J; Faes D; Beutels M; Mairesse G; Purnode P; Blankoff I; Vandergoten P; Capiau L; Allu J; Bassand JP; Kayani G;
Acta Cardiol; 2019 Aug; 74(4):309-318. PubMed ID: 30369290
[No Abstract] [Full Text] [Related]
5. International longitudinal registry of patients with atrial fibrillation at risk of stroke: Global Anticoagulant Registry in the FIELD (GARFIELD).
Kakkar AK; Mueller I; Bassand JP; Fitzmaurice DA; Goldhaber SZ; Goto S; Haas S; Hacke W; Lip GY; Mantovani LG; Verheugt FW; Jamal W; Misselwitz F; Rushton-Smith S; Turpie AG
Am Heart J; 2012 Jan; 163(1):13-19.e1. PubMed ID: 22172431
[TBL] [Abstract][Full Text] [Related]
6. Improved outcomes with European Society of Cardiology guideline-adherent antithrombotic treatment in high-risk patients with atrial fibrillation: a report from the EORP-AF General Pilot Registry.
Lip GY; Laroche C; Popescu MI; Rasmussen LH; Vitali-Serdoz L; Dan GA; Kalarus Z; Crijns HJ; Oliveira MM; Tavazzi L; Maggioni AP; Boriani G
Europace; 2015 Dec; 17(12):1777-86. PubMed ID: 26321406
[TBL] [Abstract][Full Text] [Related]
7. Evolving antithrombotic treatment patterns for patients with newly diagnosed atrial fibrillation.
Camm AJ; Accetta G; Ambrosio G; Atar D; Bassand JP; Berge E; Cools F; Fitzmaurice DA; Goldhaber SZ; Goto S; Haas S; Kayani G; Koretsune Y; Mantovani LG; Misselwitz F; Oh S; Turpie AG; Verheugt FW; Kakkar AK;
Heart; 2017 Feb; 103(4):307-314. PubMed ID: 27647168
[TBL] [Abstract][Full Text] [Related]
8. Improved risk stratification of patients with atrial fibrillation: an integrated GARFIELD-AF tool for the prediction of mortality, stroke and bleed in patients with and without anticoagulation.
Fox KAA; Lucas JE; Pieper KS; Bassand JP; Camm AJ; Fitzmaurice DA; Goldhaber SZ; Goto S; Haas S; Hacke W; Kayani G; Oto A; Mantovani LG; Misselwitz F; Piccini JP; Turpie AGG; Verheugt FWA; Kakkar AK;
BMJ Open; 2017 Dec; 7(12):e017157. PubMed ID: 29273652
[TBL] [Abstract][Full Text] [Related]
9. Guideline-Adherent Treatment for Stroke and Death in Atrial Fibrillation Patients From UK and Japanese AF Registries.
Miyazawa K; Ogawa H; Mazurek M; Shantsila E; Lane DA; Wolff A; Akao M; Lip GYH
Circ J; 2019 Nov; 83(12):2434-2442. PubMed ID: 31694989
[TBL] [Abstract][Full Text] [Related]
10. Why are outcomes different for registry patients enrolled prospectively and retrospectively? Insights from the global anticoagulant registry in the FIELD-Atrial Fibrillation (GARFIELD-AF).
Fox KAA; Accetta G; Pieper KS; Bassand JP; Camm AJ; Fitzmaurice DA; Kayani G; Kakkar AK;
Eur Heart J Qual Care Clin Outcomes; 2018 Jan; 4(1):27-35. PubMed ID: 28950344
[TBL] [Abstract][Full Text] [Related]
11. Risk profiles and antithrombotic treatment of patients newly diagnosed with atrial fibrillation at risk of stroke: perspectives from the international, observational, prospective GARFIELD registry.
Kakkar AK; Mueller I; Bassand JP; Fitzmaurice DA; Goldhaber SZ; Goto S; Haas S; Hacke W; Lip GY; Mantovani LG; Turpie AG; van Eickels M; Misselwitz F; Rushton-Smith S; Kayani G; Wilkinson P; Verheugt FW;
PLoS One; 2013; 8(5):e63479. PubMed ID: 23704912
[TBL] [Abstract][Full Text] [Related]
12. Middle East Treatment Strategies and Clinical Outcomes in Patients with Atrial Fibrillation: One-Year Follow-up Data from Garfield-AF Study.
Sayin BY; Al Mahmeed W; Ragy HI; Elbahry A; Virdone S; Kakkar AK; Ersanlı M; Oto A
Adv Ther; 2021 May; 38(5):2391-2405. PubMed ID: 33772428
[TBL] [Abstract][Full Text] [Related]
13. Does sex affect anticoagulant use for stroke prevention in nonvalvular atrial fibrillation? The prospective global anticoagulant registry in the FIELD-Atrial Fibrillation.
Lip GY; Rushton-Smith SK; Goldhaber SZ; Fitzmaurice DA; Mantovani LG; Goto S; Haas S; Bassand JP; Camm AJ; Ambrosio G; Janský P; Al Mahmeed W; Oh S; van Eickels M; Raatikainen P; Steffel J; Oto A; Kayani G; Accetta G; Kakkar AK;
Circ Cardiovasc Qual Outcomes; 2015 Mar; 8(2 Suppl 1):S12-20. PubMed ID: 25714828
[TBL] [Abstract][Full Text] [Related]
14. Stroke-prevention strategies in North American patients with atrial fibrillation: The GLORIA-AF registry program.
McIntyre WF; Conen D; Olshansky B; Halperin JL; Hayek E; Huisman MV; Lip GYH; Lu S; Healey JS
Clin Cardiol; 2018 Jun; 41(6):744-751. PubMed ID: 29546729
[TBL] [Abstract][Full Text] [Related]
15. Antithrombotic treatment patterns and stroke prevention in patients with atrial fibrillation in TURKEY: inferences from GARFIELD-AF registry.
Sayın B; Okutucu S; Yılmaz MB; Özdemir K; Aydınlar A; Şahin DY; Altun A; Açıkel S; Okuyan E; Sucu M; Öngen Z; Ersanlı MK; Yılmaz Ö; Demir M; Pekdemir H; Topsakal R; Şahiner ML; Aras D; Oto A
Anatol J Cardiol; 2019 Apr; 21(5):272-280. PubMed ID: 31062761
[TBL] [Abstract][Full Text] [Related]
16. Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry.
Sawhney JP; Kothiwale VA; Bisne V; Durgaprasad R; Jadhav P; Chopda M; Vanajakshamma V; Meena R; Vijayaraghavan G; Chawla K; Allu J; Pieper KS; John Camm A; Kakkar AK;
Indian Heart J; 2018; 70(6):828-835. PubMed ID: 30580852
[TBL] [Abstract][Full Text] [Related]
17. Stroke prevention in atrial fibrillation patients in Poland and other European countries: insights from the GARFIELD-AF registry.
Stępińska J; Kremis E; Konopka A; Wożakowska-Kapłon B; Ruszkowski P; Kukla P; Kayani G
Kardiol Pol; 2016; 74(4):362-71. PubMed ID: 26365937
[TBL] [Abstract][Full Text] [Related]
18. Optimising prediction of mortality, stroke, and major bleeding for patients with atrial fibrillation: validation of the GARFIELD-AF tool in UK primary care electronic records.
Apenteng PN; Prieto-Merino D; Hee SW; Lobban TC; Caleyachetty R; Fitzmaurice DA
Br J Gen Pract; 2023 Nov; 73(736):e816-e824. PubMed ID: 37845083
[TBL] [Abstract][Full Text] [Related]
19. Discrepancy between guidelines for stroke prevention in atrial fibrillation and practice patterns in primary care. The nationwide French AFIGP survey.
Sabouret P; Bricard M; Hermann MA; Cotté FE; Deret-Bixio L; Rushton-Smith S
Arch Cardiovasc Dis; 2015 Nov; 108(11):544-53. PubMed ID: 26113478
[TBL] [Abstract][Full Text] [Related]
20. Risk factors for death, stroke, and bleeding in 28,628 patients from the GARFIELD-AF registry: Rationale for comprehensive management of atrial fibrillation.
Bassand JP; Accetta G; Al Mahmeed W; Corbalan R; Eikelboom J; Fitzmaurice DA; Fox KAA; Gao H; Goldhaber SZ; Goto S; Haas S; Kayani G; Pieper K; Turpie AGG; van Eickels M; Verheugt FWA; Kakkar AK;
PLoS One; 2018; 13(1):e0191592. PubMed ID: 29370229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
